Successful salvage therapy using lenalidomide in a patient with relapsed multiple myeloma after allogeneic hematopoietic stem cell transplantation

被引：0
作者：
Suzuki, Tomotaka [1 ]
Kusumoto, Shigeru [1 ]
Yoshida, Tatsuya [1 ]
Mori, Fumiko [1 ]
Ito, Asahi [1 ]
Ri, Masaki [1 ]
Ishida, Takashi [1 ]
Komatsu, Hirokazu [1 ]
Niimi, Akio [1 ]
Iida, Shinsuke [1 ]
机构：
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Mizuho Ku, Nagoya, Aichi 4678601, Japan
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2013年 / 97卷 / 04期
关键词：
Multiple Myeloma; Tacrolimus; Bortezomib; Lenalidomide; Acute GVHD;
D O I：
10.1007/s12185-013-1301-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：540 / 543
页数：4
相关论文
共 50 条
  • [21] Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
    G Schilling
    T Hansen
    A Shimoni
    T Zabelina
    J-A Simon-Perez
    N C Gutierrez
    W Bethge
    P Liebisch
    R Schwerdtfeger
    M Bornhäuser
    S Otterstetter
    E M M Penas
    J Dierlamm
    F Ayuk
    D Atanackovic
    U Bacher
    C Bokemeyer
    A Zander
    J S Miguel
    A Nagler
    N Kröger
    Leukemia, 2008, 22 : 1250 - 1255
  • [22] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Kikuchi, Taku
    Mori, Takehiko
    Koda, Yuya
    Kohashi, Sumiko
    Kato, Jun
    Toyama, Takaaki
    Nakazato, Tomonori
    Aisa, Yoshinobu
    Shimizu, Takayuki
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (06) : 670 - 677
  • [23] Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Costa, Luciano J.
    Kumar, Shaji
    Dispenzieri, Angela
    Hayman, Suzanne E.
    Buadi, Francis K.
    Dingli, David
    Litzow, Mark R.
    Gertz, Morie A.
    Lacy, Martha Q.
    LEUKEMIA & LYMPHOMA, 2009, 50 (05) : 781 - 787
  • [24] Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance
    Palazzo, Meighan
    Shah, Gunjan L.
    Copelan, Olivia
    Seier, Kenneth
    Devlin, Sean M.
    Maloy, Molly
    Kenny, Sheila
    Hassoun, Hani
    Korde, Neha S.
    Lendvai, Nikoletta
    Lesokhin, Alexander M.
    Mailankody, Sham
    Chung, David J.
    Koehne, Guenther
    Landgren, C. Ola
    Landau, Heather
    Giralt, Sergio A.
    Perales, Miguel-Angel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 871 - 876
  • [25] Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Schilling, G.
    Hansen, T.
    Shimoni, A.
    Zabelina, T.
    Simon-Perez, J-A
    Gutierrez, N. C.
    Bethge, W.
    Liebisch, P.
    Schwerdtfeger, R.
    Bornhaeuser, M.
    Otterstetter, S.
    Penas, E. M. M.
    Dierlamm, J.
    Ayuk, F.
    Atanackovic, D.
    Bacher, U.
    Bokemeyer, C.
    Zander, A.
    Miguel, J. S.
    Nagler, A.
    Kroeger, N.
    LEUKEMIA, 2008, 22 (06) : 1250 - 1255
  • [26] Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma
    Baertsch, Marc-Andrea
    Fougereau, Mathilde
    Hielscher, Thomas
    Sauer, Sandra
    Breitkreutz, Iris
    Jordan, Karin
    Mueller-Tidow, Carsten
    Goldschmidt, Hartmut
    Raab, Marc-Steffen
    Hillengass, Jens
    Giesen, Nicola
    CANCERS, 2021, 13 (18)
  • [27] Autologous Stem Cell Transplantation: An Effective Salvage Therapy in Multiple Myeloma
    Lemieux, Emilie
    Hulin, Cyrille
    Caillot, Denis
    Tardy, Stephanie
    Dorvaux, Veronique
    Michel, Jessica
    Gastinne, Thomas
    Rossi, Cedric
    Legouge, Caroline
    Touzeau, Cyrille
    Planche, Lucie
    Loirat, Marion
    Lafon, Ingrid
    Moreau, Philippe
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (03) : 445 - 449
  • [28] Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: What Place, If Any?
    Sergio Giralt
    Guenther Koehne
    Current Hematologic Malignancy Reports, 2013, 8 : 284 - 290
  • [29] Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation
    Fenk, Roland
    Liese, Vanessa
    Neubauer, Florian
    Bruns, Ingmar
    Kondakci, Mustafa
    Balleisen, Sebastian
    Saure, Christian
    Schroeder, Thomas
    Haas, Rainer
    Kobbe, Guido
    LEUKEMIA & LYMPHOMA, 2011, 52 (08) : 1455 - 1462
  • [30] Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them
    Chhabra, Saurabh
    Szabo, Aniko
    Glisch, Chad
    George, Gemlyn
    Narra, Ravi K.
    Harrington, Alexandra
    Jerkins, James H.
    D'Souza, Anita
    Dhakal, Binod
    Pasquini, Marcelo C.
    Hamadani, Mehdi
    Hari, Parameswaran N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (07) : 1288 - 1297
12345